A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 922 participants.

Also called NCT07146048

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 922 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07146048
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Uganda (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07146048. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2029-02-20 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop
Acronym
GOAL-Stop
Condition
Rheumatic Heart Disease
Intervention (Drug)
Secondary Prophylaxis
Lead sponsor
Children's Hospital Medical Center, Cincinnati (class: other)
Collaborator
Uganda Heart Institute (class: other)
Collaborator
Coefficient Giving (class: other)
Collaborator
Thrasher Research Fund (class: other)

Record details

Record id
cardio:ct-nct07146048
Content hash
e25968df613a467f07ed4499cae1bcd5c6f3d685434929c7956d5a537ee3ed69